Interested? Do you feel you will benefit?
All Rights Reserved. marcus evans ® 2019
2nd Annual Real World Evidence & Data Insights Excellence
Increasing Product Value and Performance for Patients
November 5-7, 2019
Philadelphia, PA
marcus evans Noth America
What our delegates think of us:
Very informative and interesting. I’m very impressed with the knowledge of the speakers.
Allergan
This is a very informative conference; this was well organized – credit goes to the organizers.
Alcon Novartis
High quality presentations, engaged audience, well-run.
GSK Consumer
An interview with Yan Ge, Director of Data Analytics in the Data Sciences Institute at Takeda Pharmaceuticals
Ahead of the 2nd Annual Real World Evidence & Data Insights Excellence Conference, we spoke with Yan Ge of Takeda Pharmaceuticals. Yan is an industry veteran with over twenty years of experience in the Life Sciences and Healthcare Industry. Yan has built up Analytics and Data Science capabilities from scratch at three different companies including Takeda. Before joining Takeda, Yan served in data analytics leadership roles at Ascensia Diabetes, Telcare, Deloitte Consulting, Medidata and IBM. Yan holds multiple graduate degrees in Statistics, Molecular Biosciences and has an MBA on top of his Bachelor's of Science from Peking University, China.
Yan, you will be presenting on “Integrating Digital Health for New Opportunities to Better Leverage Data,” what are some key takeaways the attendees can expect from your session?
1. Data from Digital Devices and Wearables are becoming more important in RWE but still have key challenges
2. AI/ML can also play a key role in analyzing Digital Health data
3. Besides the potential of improving drug development efficiencies, Digital Health technologies and applications can also help improve patient care with better adherence and monitoring
What strategies can be used to better leverage data when utilizing digital health technologies?
1. Set up data governance process to ensure sufficient capture of business metadata, curation and harmonization of data
2. Implement a lean data lake as central repository to enable exploratory, pooled and advanced analysis of big data across from various digital health devices, platforms and technologies
3. Collaboratively engage business stakeholders and data scientists for uncovering new use cases and data insights
How can digital health maximize drugs to market more efficiently and cost effectively?
1. Drive the evolution from centralized site-based studies to remote/home-based studies
2. Improve adherence and monitoring
3. Enable real-time data capture, monitoring and analysis for Adaptive studies
In your experience, what strategies have worked best when trying to improve patient care?
1. Real-time monitoring and coaching
2. Motivating tactics including incentives and gamification to drive adherence and compliance
3. Team-care engaging stakeholders beyond the doctors to include caregivers, friends and family support
What key drivers motivated you to participate in this conference? What do you hope to gain from attending this event?
1. To get ideas and insights from leading practitioners in the field
2. Networking with KOLs and technology leaders
3. Get motivation and inspiration
Yan Ge is one of our keynote speakers for this conference
Why you should attend this marcus evans conference?
More than 14 hours of focused end-user driven case studies
-
Maximize real world evidence insights to improve value and performance
-
Leverage real world data to better determine patient populations
-
Examine new tools and technologies for efficient real world evidence analysis
-
Assess existing and forthcoming regulatory impacts to best meet expectations concerning real world evidence
-
Utilize data links to merge different sets of data from various sources
Practical insights from active practitioners in your sector
Christopher Boone
Vice President, Global Medical Epidemiology & Big Data Analysis Lead
Pfizer
Daisuke Goto
Director of Outcomes Research, Center for Observational and Real-World Evidence
Merck Research Laboratories
Jennifer L. Wong
Senior Director, Real World Evidence Strategy & Alliances, Global Medical Affairs
AstraZeneca
Harini Gopalakrishnan
RWE & Analytics Domain Leader
Sanofi
Case study:
Integrating Digital Health for New Opportunities to Better Leverage Data (7th of November at 9 AM)
• Highlighting the tole of digital health technologies in the outcomes based healthcare
• Analyzing digital health as it continues to evolve within RWE to bring drugs to market more efficiently and cost-effectively
• Digital health applications for various TAs
• Improving patient care with enhanced medication adherence and compliance support through digital health
For registration pricing and multiple attendee discounts, please contact:
Jeremy Wise
